Literature DB >> 131782

Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.

J G Levy, A G Smith, R B Whitney, R McMaster, D G Kilburn.   

Abstract

Sera from mice with large tumours from a variety of tissue types and sources have been shown to contain substances capable of suppressing the proliferative response of normal mouse lymphocytes to concanavalin A (Con A), bacterial endotoxin (LPS) and allogeneic cells. The present paper deals with studies on the nature of these inhibitory materials using mainly a methylcholanthrene-induced rhabdomyosarcoma in DBA/2J mice. It was found that a material responsible for inhibition of the Con A response eluted with immunoglobulins on Sephadex G-150 and eluted with monomeric immunoglobulin on Sephadex G-200. The component of tumour-bearer serum responsible for the suppression of the LPS response of normal lymphocytes eluted from Sephadex G-150 with the alpha and beta globulins and albumin (molecular weight less than 150,000). The immunoglobulin-containing serum fraction from tumour-bearing animals inhibited the mixed lymphocyte response, Con A response, and specific immune response to purified protein derivative (PPD) in allogeneic cell systems. It also inhibited the in vitro primary response of mouse cells to sheep red blood cells, and, to a lesser extent, the response to a T cell-independent antigen (DNP-dextran). The inhibitory activity continued to elute with monomeric IgG on Sephadex G-200 when columns were run in 1640 medium and adjusted to pH 2-5, indicating that an acid dissociable complex was not responsible for inhibitory activity. Inhibitor activity could be removed by absorption on immuno-adsorbents containing goat anti-mouse immuno-globulin, and could be recovered by acid elution from the absorbent. Inhibitor activity was not removed by immunoadsorption on columns prepared with antisera to chicken immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 131782      PMCID: PMC1445012     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

2.  Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.

Authors:  N Suciu-Foca; J Buda; J McManus; T Thiem; K Reemtsma
Journal:  Cancer Res       Date:  1973-10       Impact factor: 12.701

3.  Suppression of mitogen responses by serum from tumour-bearing mice.

Authors:  R B Whitney; J G Levy
Journal:  Eur J Cancer       Date:  1974-11       Impact factor: 9.162

4.  Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma.

Authors:  J L McCoy; L F Jerome; J H Dean; G B Cannon; T C Alford; T Doering; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

5.  Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.

Authors:  I Hellström; G A Warner; K E Hellström; H O Sjögren
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

Review 6.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

7.  The effect of tumor size on concomitant tumor immunity.

Authors:  P J Deckers; R C Davis; G A Parker; J A Mannick
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

8.  A simple cell-suspension method for transplantation of V2 carcinoma.

Authors:  D M Berkowitz; L Alexander; N K Hollenberg
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

9.  Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.

Authors:  H Kirchner; T M Chused; R B Herberman; H T Holden; D H Lavrin
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  4 in total

1.  Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.

Authors:  J G Levy; R McMaster; B Kelly; R B Whitney; D G Kilburn
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

2.  Inhibition of DNA synthesis in concanavalin A stimulated rat lymph node cells by serum from arthritic rats.

Authors:  L Binderup; E Bramm; E Arrigoni-Martelli
Journal:  Experientia       Date:  1977-03-15

3.  Tumour-associated inhibition of immediate hypersensitivity reactions in mice.

Authors:  N R Lynch; J C Salomon
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

4.  Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements.

Authors:  R D Gasocyne; R B Whitney; J G Levy
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.